Decoy Therapeutics（DCOY.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

公众及其他88.70%
个人与内部人士10.50%
机构投资者0.80%

主要股东

主要股东最新
股东
Frederick PierceCEO & Director	5.32%	3.48 万	5.06%	+3.35 万	2026/08/31
Mark RosenblumExecutive VP of Finance & CFO	1.73%	1.14 万	1.42%	+9,682.00	2026/08/31
Barbara HibnerChief Scientific Officer	0.64%	4,216.00	0.64%	+4,216.00	2026/08/31
Vanguard Capital Management, LLC	0.62%	4,034.00	--	+4,034.00	2026/06/30
Peter MarschelChief Business Officer	0.60%	3,900.00	0.60%	+3,900.00	2026/08/31
Arnold HanishIndependent Director	0.52%	3,418.00	0.52%	+3,416.00	2026/08/31
William McVicarIndependent Chairman of the Board	0.46%	3,002.00	0.46%	+3,000.00	2026/08/31
Teresa BurlesonIndependent Director	0.31%	2,002.00	0.31%	+2,000.00	2026/08/31
Jonathan LieberIndependent Director	0.31%	2,002.00	0.31%	+2,000.00	2026/08/31
Paul LammersIndependent Director	0.31%	2,001.00	0.31%	+2,000.00	2026/08/31
Patricia GauthierDirector	0.31%	2,000.00	--	+2,000.00	2026/08/31
Geode Capital Management, LLC	0.14%	910.00	0.03%	+0	2025/12/31
Tower Research Capital Europe Limited	0.04%	256.00	0.15%	-765.00	2026/06/30
David ArthurFormer Director	<0.01%	34.00	<0.01%	+0	2026/04/30
UBS Asset Management AG	<0.01%	25.00	0.10%	-521.00	2026/06/30
Caitong International Asset Management Co., Limited	<0.01%	2.00	--	+2.00	2026/06/30
Bruce McCreedyFormer Interim Chief Scientific Officer & Independent Director	<0.01%	1.00	<0.01%	+0	2025/10/24
Advisory Services Network, LLC	0.00%	0.00	<0.01%	-41.00	2026/06/30
Morgan Stanley	0.00%	0.00	<0.01%	-1.00	2026/06/30
Armistice Capital LLC	0.00%	0.00	0.08%	-421.00	2026/06/09